Comment on

• Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.

  Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. Hope TA, et al. JAMA Oncol. 2021 Nov 1;7(11):1635-1642. doi: 10.1001/jamaoncol.2021.3771. JAMA Oncol. 2021. PMID: 34529005 Free PMC article. Clinical Trial.
• Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer.

  Aggarwal R, Rydzewski NR, Zhang L, Foye A, Kim W, Helzer KT, Bakhtiar H, Chang SL, Perry MD, Gleave M, Reiter RE, Huang J, Evans CP, Alumkal JJ, Lang JM, Yu M, Quigley DA, Sjöström M, Small EJ, Feng FY, Zhao SG. Aggarwal R, et al. JAMA Oncol. 2021 Nov 1;7(11):1644-1652. doi: 10.1001/jamaoncol.2021.3987. JAMA Oncol. 2021. PMID: 34554200 Free PMC article.
• Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.

  Leapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR, Gross CP, Ma X. Leapman MS, et al. JAMA Oncol. 2022 Jan 1;8(1):41-47. doi: 10.1001/jamaoncol.2021.5143. JAMA Oncol. 2022. PMID: 34762100 Free PMC article.
• Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy Over 2 Years: Results From a Statewide Surgical Improvement Collaborative.

  Agochukwu-Mmonu N, Qi J, Dunn RL, Montie J, Wittmann D, Miller D, Martin R, Kim T, Johnston WK 3rd, Peabody J. Agochukwu-Mmonu N, et al. JAMA Surg. 2022 Feb 1;157(2):136-144. doi: 10.1001/jamasurg.2021.6215. JAMA Surg. 2022. PMID: 34851369 Free PMC article.